Goodwin Procter LLP advised Hillhouse Capital on its investment in Everest Medicines as a co-lead investor in Everest Medicine’s Series C financing of $310 million. Everest…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
